REQUEST A DEMO
Total
USD $0.00
Search more companies

Aditi Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Aditi Pharmaceuticals Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Aditi Pharmaceuticals Pvt Ltd is an enterprise located in India, with the main office in Solapur. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on May 07, 1985. There are currently 95 (2025) people employed by Aditi Pharmaceuticals Pvt Ltd. In 2025, the company reported a net sales revenue drop of 8.22%. There was a total growth of 3.8% in Aditi Pharmaceuticals Pvt Ltd’s total assets over the same period. In, 2025, the company’s net profit margin decreased by 0.51%.

Legal Address
E/65/66 Midc Akkalkot Road
Solapur; Maharashtra; Postal Code: 413006

Contact Details: Purchase the Aditi Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Aditi Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Aditi Pharmaceuticals Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Aditi Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
May 07, 1985
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Aditi Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.22%
Total Operating Revenue
-7.84%
Operating Profit
-20.52%
EBITDA
-15.7%
Net Profit/Loss for the Period
-20.54%
Total Assets
3.8%
Total Equity
4.8%
Operating Profit Margin
-0.67%
Net Profit Margin
-0.51%
Return on Equity (ROE)
-1.46%
Quick Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?